WINNING STRATEGIES WASHINGTON for KALEO
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Pharmaceutical drug development including epinephrine for anaphylaxis
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Taxation/Internal Revenue Code TAX
monitor tax reform provisions including the repeal of the ACA individual mandate.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MOLLY MCDONNELL | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Health Issues HCR
Reducing opioid overdose deaths; implementation of HR 3680/S. 2256 provisions related to naloxone included in the conference report on S. 524, the Comprehensive Addiction and Recovery Act S.771 Improving Access to Affordable Prescription Drugs Act, S.469 Affordable and Safe Prescription Drug Importation Act; monitoring policies and regulations related to the President's declaration of the opioid crisis as a public health emergency under the Public Health Service Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | n/a |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
| CHARLA PENN | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd |
| CHELSEY PENROD HICKMAN | CoS, Rep. Kay Granger; LA Sen. Larry Craig |
| ROBERT ZUCKER | LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.